✦ LIBER ✦

The effect of the dopamine D2 receptor antagonist raclopride on the pattern of licking microstructure induced by midazolam in the rat

✍ Scribed by Suzanne Higgs; Steven John Cooper

Book ID: 114013529
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 695 KB
Volume: 409
Category: Article
ISSN: 0014-2999
DOI: 10.1016/s0014-2999(00)00802-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancement of antipsychotic-like effect

Enhancement of antipsychotic-like effects by combined treatment with the α1-adrenoceptor antagonist prazosin and the dopamine D2receptor antagonist raclopride in rats

✍ M.-L. Wadenberg; P. Hertel; R. Fernholm; K. Hygge Blakeman; S. Ahlenius; T. H. S 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 103 KB

The selective D2 dopamine receptor antag

The selective D2 dopamine receptor antagonist eticlopride counteracts the ejaculatio praecox induced by the selective D2 dopamine agonist SND 919 in the rat

✍ F. Ferrari; D. Giuliani 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Enhancement of antipsychotic-like proper

Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat

✍ M-L. Wadenberg; Peter Salmi; Patricia Jimenez; Torgny Svensson; Sven Ahlenius 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 529 KB

Effect of the dopamine D1-like receptor

Effect of the dopamine D1-like receptor antagonist SCH 23390 on the microstructure of ingestive behaviour in water-deprived rats licking for water and NaCl solutions

✍ Adriana Galistu; Paolo S. D'Aquila 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 267 KB

The effects of selective dopamine D1 or

The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats

✍ Diane C. Hoffman; Richard J. Beninger 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 875 KB

Attenuation of the locomotor-sensitizing

Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride

✍ Roy A. Wise; William A. Carlezon Jr. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Injections of the selective D, dopamine agonist bromocriptine (5.0 mg/ kg, IP) produced progressively stronger locomotion over 10 days of repeated testing. Concurrent treatment with either the D, antagonist SCH 23390 (0.01 or 0.1 mg/kg, IP) or the D, antagonist raclopride (0.1 or 1.0 mg/kg, IP) supp